Although abortion is legal in Zambia under a variety of broad conditions, unsafe abortion remains common. The purpose of this project was to compare the financial costs for women when they have an induced abortion at a facility, with costs for an induced abortion outside a facility, followed by care for abortion-related complications. We gathered household wealth data at one point in time (T1) and longitudinal qualitative data at two points in time (T1 and T2, three-four months later), in Lusaka and Kafue districts, between 2014 and 2015. The data were collected from women (n = 38) obtaining a legal termination of pregnancy (TOP), or care for unsafe abortions (CUA). The women were recruited from four health facilities (two hospitals and two private clinics, one of each per district). At T2, CUA cost women, on average, 520 ZMW (USD 81), while TOP cost women, on average, 396 ZMW (USD 62). About two-thirds of the costs had been incurred by T1, while an additional one-third of the total costs was incurred between T1 and T2. Women in all three wealth tertiles sought a TOP in a health facility or an unsafe abortion outside a facility. Women who obtained CUA tended to be further removed from the money that was used to pay for their abortion care. Women's financial dependence leaves them unequipped to manage a financial shock such as an abortion. Improved TOP and post-abortion care are needed to reduce the health sequelae women experience after both types of abortion-related care.
机构:
Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Karolinska Univ Hosp, WHO Ctr Human Reprod, Stockholm, SwedenKarolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
机构:
Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Karolinska Univ Hosp, WHO Ctr Human Reprod, Stockholm, SwedenKarolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Gemzell-Danielsson, Kristina
Tumwesigye, Nazarius Mbona
论文数: 0引用数: 0
h-index: 0
机构:
Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, UgandaKarolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Tumwesigye, Nazarius Mbona
论文数: 引用数:
h-index:
机构:
Atuhairwe, Susan
Faxelid, Elisabeth
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, SwedenKarolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Faxelid, Elisabeth
Klingberg-Allvin, Marie
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, SwedenKarolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
机构:
Takeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, EnglandTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Campbell-Hill, S.
Stein, D.
论文数: 0引用数: 0
h-index: 0
机构:
Evidera, London, EnglandTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Stein, D.
Soni, M.
论文数: 0引用数: 0
h-index: 0
机构:
Evidera, London, EnglandTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Soni, M.
Coombs, C.
论文数: 0引用数: 0
h-index: 0
机构:
Evidera, Bethesda, MD USATakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Coombs, C.
Ratsch, B.
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharma Vertrieb GmbH & Co KG, Market Access & Publ Affairs, Berlin, GermanyTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Ratsch, B.
Khalid, J. M.
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, EnglandTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England
Khalid, J. M.
Minda, K.
论文数: 0引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Int AG, Zurich, SwitzerlandTakeda Dev Ctr Europe Ltd, Evidence & Value Generat, London, England